Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
ULTRAGENYX PHARMACEUTICAL IN
CUSIP: 90400D908
Class: OPTION
Ally Bridge Group (NY) LLC's Holding History (CIK: 0001822947)
Note: Option positions (PUT/CALL) are excluded.
Q2 2025
Shares
1,600
Value ($000)
$5,818
Avg Close
—
Range
—
Period
Shares
Value ($000)
Average Close
Price Range
Q2 2025
1,600
$5,818
—
—